Solid Thumbs-Up on CMS Price Negotiation
For years, the notion that the federal government would negotiate the prices that the Medicare program pays for drugs was
Read MoreFor years, the notion that the federal government would negotiate the prices that the Medicare program pays for drugs was
Read MoreWhen we think of Employees in the healthcare industry, our mind often goes to doctors, nurses, and other hospital workers.
Read MoreIs a specter haunting Europe? Will Eli Lilly usurp Johnson & Johnson? And what does “Vowst” call to mind? We
Read MoreA molecular biologist examines wastewater samples for pathogens in the safety laboratory at the Max Delbrück Center for Molecular Medicine
Read More“Epic” and “enormous” were two of the words used by European Commission Vice-President Margaritis Schinas to describe the biggest planned
Read MoreSAN FRANCISCO, April 25, 2023 /PRNewswire/ — The global pharmaceutical packaging industry size was valued at USD 117 billion in
Read MoreThe EU is planning a compulsory licensing system to allow it to take control of the manufacture of drugs and
Read MoreNearly a decade after AstraZeneca fended off a hostile takeover approach from US rival Pfizer, the British drug firm has
Read MoreIn the last few weeks, three of the biggest insulin-making companies have cut their prices for insulin. This comes as
Read MoreDrug makers Sun Pharma and Hetero are recalling products in the US market for manufacturing issues, according to the US
Read More